Text Size
Welcome to Herbal Solutions, We are Long Beach's,Orange County's, & South Bay's premier Medical Marijuana provider. We are 100% self-contained! We grow all of our own plants and produce all of our own baked goods, candies and capsules. Herbal Solutions stays in Strict Compliance with Long Beach Medical Marijuana Codes. Because we are our own provider we can offer superior exotic strains at the lowest prices. Our facilities are open 7 days a week from 10am to 8pm. We have 24 hour security and our facilities are second to none in cleanliness.

Harbor City Location

25937 Western Ave 

Harbor City, CA 90717


Tasty Treats Each day, we bake everything from scratch using the finest ingredients and oils from the finest strains. From chocolate chip cookies to bunt cakes, our treats are meant to bring you back to a time when a bite of something sweet could make the world a little brighter.  All of our baked goods are labeled with the exact amount of THC and CBD, so you can monitor your daily intake of medicine.  Our baked goods come in three different levels of potency; 30mg, 60mg and 120mg.  We also offer hard candies, chocolate bars, peanut butter cups, lollipops and puppy chow.  Come on in today and try one of our tasty treats.
Laboratory Testing Here at Herbal Solutions all of our medicine is safety screened for pathogenic molds. In addition, we have a breakthrough new way of self-titration. All cannabis flowers and concentrates will be tested for THC and CBD percentages. You may ask what does this mean for you as a patient? What it means is that you will be able to self regulate the amount of THC or CBD that you ingest. We believe this is extremely important for the patient know how much is needed for their particular ailments. The breakdown is this: one gram is equivalent to 1,000mg. Therefore, if a cannabis strain has 20% THC and 1% CBD one gram consumed is the equivalent of 200mg of THC and 10mg of CBD. 
State of the Art Facilities Herbal Solutions has been dedicated to the well-being of our members since 2006. We are proud to provide clean and safe access with our in-house safety regulations and strict standards. All locations have security officers during all hours of operation and strict security measures to insure the safety of our patient members.

Deals of the Day!



FREE GRAM over $50, Two Free Grams over $100, & Four Free Grams over $150!

25% Delta Vape Flavors!

25% off all Edibles

25% off all concentrates!

25% off Delta 9 Vape Flavors

Pick two of any of our Daily Specials!

25% off of all Edibles &  FREE GRAM over $50, Two Free Grams over $100, & Four Free Grams over $150

California Marijuana Program

The Medical Marijuana Program (MMP) was established to provide a voluntary medical marijuana identification card issuance and registry program for qualified patients and their caregivers.  The web-based registry system allows law enforcement and the public to verify the validity of qualified patient or caregiver's card as authorization to possess, grow, transport and/or use Medical Marijuana in California.  To facilitate the verification of authorized cardholders, the verification database is available on the internet at www.calmmp.ca.gov.

Read More


Fees for Medical Marijuana

All administrative costs for the Medical Marijuana Program, at both the State and county level are fee supported.

Senate Bill 420 (Chapter 875, Statutes of 2003) requires the California Department of Health Services (CDHS), now the California Department of Public Health (CDPH), to establish application fees for persons seeking to obtain, renew or replace identification cards.  The state’s portion of the fee is required to be sufficient to cover the expenses incurred by CDPH, including start up and other costs.  Likewise, each county program may add their costs to the total fee to support expenses incurred by the county program. 

Read More

Patient Appreciation Day!

First Day of Every Month!

15% off flowers and 25% off edibles and concentrates!

ShareShare on LinkedIn


There are many variations in the knowledge cultivated on the medical uses of cannabis and cannabinoids in different diseases. For nausea and vomiting associated with cancer chemotherapy, anorexia/cachexia in HIV/AIDS, chronic, especially neuropathic pain, spasticity in multiple sclerosis and spinal cord injury there is strong evidence for medical benefits. For many other indications, such as epilepsy, pruritus and depression there is much less available data. However, the scientific evidence for a specific indication does not necessarily reflect the actual therapeutic potential for a given disease.

Clinical studies with single cannabinoids or whole plant preparations (smoked cannabis, cannabis extract) have often been inspired by positive anecdotal experiences of patients employing crude cannabis products. The anti-emetic, the appetite enhancing, relaxing effects, analgesia, and therapeutic use in Tourette’s syndrome were all discovered in this manner.

Incidental observations have also revealed therapeutically useful effects. This occurred in a study with patients with Alzheimer’s disease wherein the primary issue was an examination of the appetite-stimulating effects of THC. Not only appetite and body weight increased, but disturbed behaviour among the patients also decreased. The discovery of decreased intraocular pressure with THC administration was also serendipitous. Additional interesting indications that have not been scientifically investigated, but remain common problems in modern medicine may benefit from treatment with cannabis or cannabinoids. For this reason, surveys have been conducted questioning individuals that use cannabis therapeutically. They were conducted either as oral non-standardized interviews in the course of investigations of state or scientific institutions on the therapeutic potential of cannabis or as anonymous surveys using standardized questionnaires.


Twitter Feed

Facebook Fan Feed

Medical Applications

In many clinical trials of THC, nabilone and cannabis, a beneficial effect on spasticity caused by multiple sclerosis or spinal cord injury has been observed. Among other positively influenced symptoms were pain, paraesthesia, tremor and ataxia. In some studies improved bladder control was observed. There is also some anecdotal evidence of a benefit of cannabis in spasticity due to lesions of the brain. Cannabis can limit the muscle pain and spasticity caused by multiple sclerosis as well as relieving tremor and unsteadiness of gait.
Experiments examining the anti-asthmatic effect of THC or cannabis and are all acute studies. The effects of a cannabis cigarette (2% THC) or oral THC (15 mg), respectively, approximately correspond to those obtained with therapeutic doses of common bronchodilator drugs (salbutamol, isoprenaline). Since inhalation of cannabis products may irritate the mucous membranes, oral administration or another alternative delivery system would be preferable. Very few patients developed bronchoconstriction after inhalation of THC.
In a number of painful syndromes secondary to inflammatory processes (e.g. ulcerative colitis, arthritis), cannabis products may act not only as analgesics but also demonstrate anti-inflammatory potential. Patients with Crohn’s disease report subjective benefits from cannabis, including pain relief and increased appetite. For example, some patients employing cannabis report a decrease in their need for steroidal and nonsteroidal anti-inflammatory drugs. Moreover there are some reports of positive effects of cannabis self-medication in allergic conditions. It is as yet unclear whether cannabis products may have a relevant effects on causative processes of autoimmune diseases.
According to historical and modern case reports cannabis is a good remedy to combat withdrawal in dependency on benzodiazepines, opiates and alcohol. For this reason, some have referred to it as a gateway drug back. In this context, both the reduction of physical withdrawal symptoms and stress connected with discontinuance of drug abuse may play a role in its observed benefits.
Cannabis can alleviate the chronic, often debilitating pain caused by a myriad of disorders and injuries. Large clinical studies have proven analgesic properties of cannabis products. Among possible indications are neuropathic pain due to multiple sclerosis, damage of the brachial plexus and HIV infection, pain in rheumatoid arthritis, cancer pain, headache, menstrual pain, chronic bowel inflammation and neuralgias. Combination with opioids is possible.
During a systematic investigation of its effects in healthy cannabis users, it was observed that cannabis reduces intraocular pressure, thereby alleviating the pain and slowing, even sometimes stopping, the progress of the condition. A number of studies in healthy individuals and glaucoma patients with cannabis and several natural and synthetic cannabinoids have been conducted. Cannabis decreases intraocular pressure by an average 25-30%, occasionally up to 50%. Some non-psychotropic cannabinoids, and to a lesser extent, some non-cannabinoid constituents of the hemp plant also decrease intraocular pressure.
Cannabis is an anti-emetic, it relieves nausea and vomiting. Treatment of side effects associated with antineoplastic therapy is the indication for cannabinoids which has been most documented, with about 40 studies (THC, nabilone, other THC analogues, cannabis). THC has to be dosed relatively highly, so that resultant side effects may occur comparatively frequently. There are no comparisons of THC to the modern serotonin antagonists. Some recent investigations have shown that THC in low doses improves the efficacy of other antiemetic drugs if given together. In folk medicine cannabinoids are popular and are often used in various causes of nausea including AIDS, cancer and hepatitis.
There are some positive anecdotal reports of therapeutic response to cannabis in Tourette’s syndrome, dystonia and tardive dyskinesia. The use in Tourette’s syndrome is currently being investigated in clinical studies. Many patients achieve a modest improvement, however some show a considerable response or even complete symptom control. In some MS patients, benefits on ataxia and reduction of tremor have been observed following the administration of THC. Despite occasional positive reports, no objective success has been found in parkinsonism or Huntington disease. However, cannabis products may prove useful in levodopa-induced dyskinesia in Parkinson disease without worsening the primary symptoms.
An improvement of mood in reactive depression has been observed in several clinical studies with THC. There are additional case reports claiming benefit of cannabinoids in other psychiatric symptoms and diseases, such as sleep disorders, anxiety disorders, bipolar disorders, and dysthymia. Various authors have expressed different viewpoints concerning psychiatric syndromes and cannabis. While some emphasize the problems caused by cannabis, others promote the therapeutic possibilities. Quite possibly cannabis products may be either beneficial or harmful, depending on the particular case. The attending physician and the patient should be open to a critical examination of the topic, and a frankness to both possibilities.

New Patients & Referrals

15% Off of Everything, Plus a FREE pack of D-9 Capsules

Community Poll

What is Your Favorite Marijuana Product

Restore Default Settings